Skip to content

stanozolol

← Previous: stamulumab | 🏠 All Substances | 📊 Complete Table | Next: stenbolone →

OPSS Properties

Classifications6000
DEA ScheduleSchedule III
ReasonControlled substance: Schedule III
Also Known As
  • 17-beta-hydroxy-17-alpha-methylandrostano(3,2-c)pyrazole
  • Winstrol-V
  • 17alpha-methyl-17beta-hydroxy-5alphaandrost-2-eno[3,2-c]-pyrazole
  • 17α-methyl-17β-hydroxy-[5α]-androst-2-eno[3,2-c]-pyrazole
  • androstanazole
  • 17β-hydroxy-17α-methylandrostano(3,2-c)pyrazole
  • Winstrol
  • androstanazol
  • 17α-Methylpyrazolo[4',3':2,3]-5α-androstan-17β-ol
Prohibited BecauseDEA Controlled Substance List: Schedule III (DEA Controlled Substance List: Schedule III)
WADA S1: Anabolic Agents (WADA Prohibited List S1: Anabolic Agents)
Added to DatabaseDecember 30, 2025
Source Last UpdatedJuly 29, 2024
GUID97f9201e-51bd-4d5f-aea3-2350ba473522

External Resources

UNII: 4R1VB9P8V3 · CAS: 10418-03-8

PubChem Properties

Chemical Structure

Interactive 3D Structure

Molecular FormulaC21H32N2O
Molecular Weight328.5 g/mol
IUPAC Name(1S,2S,10S,13R,14S,17S,18S)-2,17,18-trimethyl-6,7-diazapentacyclo[11.7.0.02,10.04,8.014,18]icosa-4(8),5-dien-17-ol
InChIKeyLKAJKIOFIWVMDJ-IYRCEVNGSA-N

📊 Complete Table | 🏠 All Substances

Substance 800 of 880